Skip to search
Skip to main content
Back to Search
Start Over
Venetoclax in relapsed/refractory chronic lymphocytic leukemia (CLL) with 17p deletion: outcome and minimal residual disease from the full population of the pivotal M13-982 trial
Authors :
Chyla, Brenda Stilgenbauer, Stephan Eichhorst, Barbara Schetelig, Johannes Munir, Talha Hillmen, Peter Seymour, John F. Roberts, Andrew W. Coutre, Steven Jurczak, Wojciech Mulligan, Stephen P. Puvvada, Soham Wendtner, Clemens Davids, Matthew S. Boettcher, Sebastian Cerri, Elisa Zhou, Lang Popovic, Relja Poteracki, Mia Arzt, Jennifer Kim, Su Young Verdugo, Maria Bhathena, Anahita Wierda, William Hallek, Michael Chyla, Brenda Stilgenbauer, Stephan Eichhorst, Barbara Schetelig, Johannes Munir, Talha Hillmen, Peter Seymour, John F. Roberts, Andrew W. Coutre, Steven Jurczak, Wojciech Mulligan, Stephen P. Puvvada, Soham Wendtner, Clemens Davids, Matthew S. Boettcher, Sebastian Cerri, Elisa Zhou, Lang Popovic, Relja Poteracki, Mia Arzt, Jennifer Kim, Su Young Verdugo, Maria Bhathena, Anahita Wierda, William Hallek, Michael
Publication Year :
2017
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1201321445
Document Type :
Electronic Resource